![]() ![]() | Trepte, P.* , Secker, C.* , Olivet, J.* , Blavier, J.* , Kostova, S., Maseko, S. B., Minia, I., Silva Ramos, E., Cassonnet, P., Golusik, S., Zenkner, M., Beetz, S., Liebich, M. J., Scharek, N., Schütz, A., Sperling, M., Lisurek, M., Wang, Y., Spirohn, K., ... Wanker, E. E.*. (April 2024). AI-guided pipeline for protein-protein interaction drug discovery identifies a SARS-CoV-2 inhibitor. Molecular Systems Biology, 20 (4), 428 - 457. doi:10.1038/s44320-024-00019-8 ![]() * These authors have contributed equally to this work. |
![]() ![]() | Maseko, S. B., Brammerloo, Y., Van Molle, I., Sogues, A., Martin, C., Gorgulla, C., Plant, E., Olivet, J., Blavier, J., Ntombela, T., Delvigne, F., Arthanari, H., El Hajj, H., Bazarbachi, A., Van Lint, C., Salehi-Ashtiani, K., Remaut, H., Ballet, S., Volkov, A. N., & Twizere, J.-C. (21 July 2023). Identification of small molecule antivirals against HTLV-1 by targeting the hDLG1-Tax-1 protein-protein interaction. Antiviral Research, 217, 105675. doi:10.1016/j.antiviral.2023.105675 ![]() |
![]() ![]() | Olivet, J., Maseko, S. B., Volkov, A. N., Salehi-Ashtiani, K., Das, K., Calderwood, M. A., Twizere, J.-C.* , & Gorgulla, C.*. (2022). A systematic approach to identify host targets and rapidly deliver broad-spectrum antivirals. Molecular Therapy. doi:10.1016/j.ymthe.2022.02.015 ![]() * These authors have contributed equally to this work. |
Olivet, J. (2021). Selective disruption of histone deacetylase complexes by small-molecule inhibitors of protein interactions [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/261131 |
![]() ![]() | Kerselidou, D., Dohai, B. S., Nelson, D. R., Daakour, S., De Cock, N., Hassoun, Z. E. O., Kim, D.-K., Olivet, J., El Assal, D. C., Jaiswal, A., Alzahmi, A., Saha, D., Pain, C., Matthijssens, F., Lemaitre, P., Herfs, M., Chapuis, J., Ghesquiere, B., Vertommen, D., ... Twizere, J.-C. (2021). Alternative glycosylation controls endoplasmic reticulum dynamics and tubular extension in mammalian cells. Science Advances, 7 (19). doi:10.1126/sciadv.abe8349 ![]() |
![]() ![]() | Vandermeulen, C., O'Grady, T., Wayet, J., Galvan, B., Maseko, S. B., Cherkaoui, M., Desbuleux, A., Coppin, G., Olivet, J., Ben Ameur, L., Kataoka, K., Ogawa, S., Hermine, O., Marcais, A., Thiry, M., Mortreux, F., Calderwood, M. A., Van Weyenbergh, J., Peloponese, J.-M., ... Twizere, J.-C. (2021). The HTLV-1 viral oncoproteins Tax and HBZ reprogram the cellular mRNA splicing landscape. PLoS Pathogens, 17 (9), 1009919. doi:10.1371/journal.ppat.1009919 ![]() |
![]() ![]() | Olivet, J. (05 March 2019). Systematic assessment of druggable cavities in a histone deacetylase complex [Poster presentation]. Phenotypic Drug Discovery: Recent Advances and Insights from Chemical and Systems Biology (C1), Breckenridge, Colorado, United States. |
![]() ![]() | Choi, S. G., Olivet, J., Cassonnet, P., Vidalain, P.-O., Luck, K., Lambourne, L., Spirohn, K., Lemmens, I., Dos Santos, M., Demeret, C., Jones, L., Rangarajan, S., Bian, W., Coutant, E. P., Janin, Y. L., van der Werf, S., Trepte, P., Wanker, E. E., De Las Rivas, J., ... Jacob, Y. (2019). Maximizing binary interactome mapping with a minimal number of assays. Nature Communications, 10 (1), 3907. doi:10.1038/s41467-019-11809-2 ![]() |